Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada flag Canada · Delayed Price · Currency is CAD
2.800
-0.140 (-4.76%)
Jul 15, 2025, 3:59 PM EDT
21.74%
Market Cap 90.32M
Revenue (ttm) 155.71M
Net Income (ttm) 3.23M
Shares Out 32.26M
EPS (ttm) 0.11
PE Ratio 24.35
Forward PE 11.63
Dividend n/a
Ex-Dividend Date n/a
Volume 28,312
Average Volume 46,780
Open 2.930
Previous Close 2.940
Day's Range 2.800 - 2.930
52-Week Range 1.710 - 5.560
Beta 2.04
RSI 45.56
Earnings Date Jun 23, 2025

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology and rare diseases. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, s treosulfan for injec... [Read more]

Sector Healthcare
CEO Kenneth d'Entremont
Employees 91
Stock Exchange Toronto Stock Exchange
Ticker Symbol MDP
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.